Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest aortic aneurysm Stories

2011-10-14 10:52:00

CLEVELAND, Oct. 14, 2011 /PRNewswire/ -- Aortic pathologies such as aneurysms, arterial penetrating ulcers, intramural hematomas and dissections are potentially life-threatening since the aorta is the major artery that allows blood to leave the heart. Historically, the surgical treatment for aortic pathologies has been thoracotomy, repair or replacement of the thoracic aorta, which has a high rate of postoperative complications and a nearly 40 percent rate of mortality in emergency cases....

2011-09-29 23:34:13

Clinicians from across disciplines set forth strategies to improve patient care, save lives Peripheral artery disease, or "PAD," is a common and dangerous condition that affects tens of millions of Americans -- often unknowingly -- and can restrict blood flow to the legs, kidneys or other vital organs. PAD, which remains underdiagnosed, is often a sign of a more widespread accumulation of fatty deposits in the heart, brain or legs and, if untreated, it is one of the most common causes of...

2011-09-13 23:10:03

While the incidence of the life-threatening condition of aortic dissection is significantly higher than in the general population, it remains low among patients with the congenital heart defect, bicuspid aortic valve; however, the incidence of aortic aneurysms is significantly high, according to a study in the September 14 issue of JAMA. Bicuspid aortic valve (BAV; defect of the aortic valve that results in the formation of two flaps that open and close, instead of the normal three) is the...

2011-09-12 12:09:44

Multi-institutional study reveals risk factor that doubles chance of developing silent killer Richard Holbrooke, John Ritter, Lucille Ball, Jonathan Larson and Great Britain's King George II were all taken by the same silent killer: an acute aortic dissection. Now, scientists led by researchers at The University of Texas Health Science Center at Houston (UTHealth) and Baylor College of Medicine (BCM) have found an association with a common genetic variant in the population that...

2011-08-17 08:15:00

IRVINE, Calif., Aug. 17, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today that Judge Tanya Walton Pratt of the United States District Court for the Southern District of Indiana in Indianapolis has issued a Markman ruling in the ongoing patent infringement lawsuit filed against the Company by Cook Medical. In a Markman ruling, the court determines the meaning of disputed patent claim terms at...

2011-08-08 08:00:00

IRVINE, Calif., Aug. 8, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today that the first U.S. commercial implant of the Company's AFX(TM) Endovascular AAA System was performed at Edward Hines, Jr. VA Hospital in Chicago, IL. The procedure was performed by Ross Milner, M.D., F.A.C.S., Associate Professor and Chief of Vascular Surgery & Endovascular Therapy at Loyola University in Chicago,...

2011-08-03 15:15:00

IRVINE, Calif., Aug. 3, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at two upcoming investor conferences. The first presentation will be at the 31st Annual Canaccord Genuity Growth Conference in Boston, MA. Event: 31st Annual Canaccord Genuity Growth Conference Date: Thursday, August...

2011-07-26 21:08:30

Stent makes 'coiling' surgery more promising option The addition of a simple stent can help prevent potentially lethal blood vessel bulges in the brain from recurring after they are repaired in a minimally invasive "coiling" procedure, according to new research by Johns Hopkins physicians. A report on the research, published in the July Journal of Neurointerventional Surgery, could make coiling a more viable option for the 30,000 people diagnosed with brain aneurysms each year in the United...

2011-07-25 13:19:00

SANTA ROSA, Calif., July 25, 2011 /PRNewswire/ -- TriVascular, Inc. today announced the successful treatment of the first 5 patients in the OVATION study, a multicenter, prospective, European Post Market Registry. The patients were treated in Germany at Stadtisches Klinikum, Karlsruhe by Prof. Martin Storck and at Universitares Herz und Gefasszentrum, Hamburg by Dr. Hans Krankenberg. "It is an honor to be the first site to enroll a patient in TriVascular's OVATION study. Ovation's...

2011-07-18 07:30:00

IRVINE, Calif., and BURLINGTON, Mass., July 18, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, and LeMaitre Vascular, Inc. (Nasdaq: LMAT), provider of peripheral vascular devices and implants, announced today that the companies have entered into an early termination agreement for LeMaitre's distribution rights of Endologix's aortic endovascular products in Europe. Under the terms of the agreement,...